Long-Term Liabilities: The sum of all non-current liabilities.
Brainstorm Cell Therapeutics Inc. (BCLI) had Long-Term Liabilities of $0.13M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-2.86M |
|
-- |
|
-- |
|
$3.09M |
|
$-3.09M |
|
$0.23M |
|
$-2.86M |
|
$-2.86M |
|
$-2.86M |
|
$-2.86M |
|
$-2.86M |
|
$-2.86M |
|
$-3.09M |
|
$-3.04M |
|
6.34M |
|
6.34M |
|
$-0.45 |
|
$-0.45 |
|
| Balance Sheet Financials | |
$2.33M |
|
$0.38M |
|
$1.24M |
|
$3.57M |
|
$10.90M |
|
-- |
|
|
Long-Term Liabilities |
$0.13M |
$11.03M |
|
$-7.46M |
|
$-7.46M |
|
$-7.46M |
|
7.91M |
|
| Cash Flow Statement Financials | |
$-1.63M |
|
-- |
|
$3.09M |
|
$0.37M |
|
$1.83M |
|
$1.46M |
|
$0.72M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.21 |
|
-- |
|
-- |
|
-- |
|
-0.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.63M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
38.41% |
|
38.41% |
|
-80.20% |
|
38.41% |
|
$-0.94 |
|
$-0.26 |
|
$-0.26 |
|